Is Takeda Pharmaceutical Company Limited (TAK) One of the Best Healthcare Stocks to Buy for 2026?
Takeda Pharmaceutical Company Limited (NYSE:TAK) is one of the best healthcare stocks to buy for 2026.
Takeda Pharmaceutical Co Ltd (TAK)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bayforest Capital Theodoros Tsagaris | 14,990 | $233,694 | -25% | 0.17% |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 4,123,523 | $64,285,724 | 0.01% | |
| 2. | 1,495,746 | $23,318,677 | 2.82% | |
| 3. | 260,804 | $4,065,934 | 1.13% | |
| 4. | 217,528 | $3,391,267 | 0% | |
| 5. | 166,783 | $2,600,147 | 0.64% |
News See All
12 Best Healthcare Stocks to Buy for 2026
Artificial Intelligence has been the catalyst behind the blockbuster rally in equity markets over the past two years.
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2026 Earnings Call Transcript
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q3 2026 Earnings Call Transcript January 29, 2026Takeda Pharmaceutical Company Limited misses on earnings expectations.
13 Best Growth Stocks Under $25 to Buy Right Now
Recently, there have been concerns around the surge of fraudulent loans and private credit quality issues in the US.
Takeda Pharmaceutical Company Limited (TAK) Advances γδ T Cell Cancer Treatments
Takeda Pharmaceutical Company Limited (NYSE:TAK), a global biopharmaceutical leader, is advancing cancer treatment through novel immuno-oncology strategies focused on the innate immune system.
11 Best Cancer Stocks to Buy Right Now
Cancer remains the second leading cause of death globally, after heart disease.
13 Best Japanese Stocks to Buy According to Hedge Funds
Additionally, Japanese government bond yields also moved higher. On Monday, the yield on the 10-year government bond increased by 5.5 basis points to reach 1.554% at 11.20 a.m. local time.
Protagonist Therapeutics, Takeda Pharmaceutical Announce Positive Phase 3 Rusfertide Results for Polycythemia Vera
Protagonist Therapeutics Inc. (NASDAQ:PTGX) is one of the best mid cap growth stocks to invest in now.
Takeda Reports Adcetris Combo Approved by EC for Hodgkin Lymphoma
Takeda Pharmaceutical Company Limited (NYSE:TAK)'s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized by the European Commission on June 3, 2025, for newly diagnosed adult patients...
Takeda Pharmaceutical Company Limited (NYSE:TAK) Q4 2024 Earnings Call Transcript
Christopher O’Reilly: Thank you very much for taking time out of their busy schedule to join our earnings announcement for FY '24 for Takeda. I'm the master of ceremony, Head of IR.